Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGILENT TECHNOLOGIES, INC.A · Entity 3062 | Director | March 19, 2026 | March 23, 2026 |
| Varex Imaging CorpVREX · Entity 5135 | Director | February 16, 2017 | February 20, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGILENT TECHNOLOGIES, INC.
Report date March 19, 2026 · Filed March 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,368.606 |
Reported balance
After 2026-03-19 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-19 · Grant · Acquired 2,158 · Balance 20,368.606 F1: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. F2: 144.124 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant.
F2: 144.124 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock.
Varex Imaging Corp
Report date February 16, 2017 · Filed February 20, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,948 |
Reported balance
After 2018-02-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-02-15 · Exercise / conversion · Acquired 5,148 · Balance 24,948 F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2: These shares were acquired in connection with the company's separation from Varian Medical Systems, Inc. and were inadvertently omitted from column 5 in the Form 4 dated February 17, 2017 |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-02-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-02-15 · Exercise / conversion · Disposed 5,148 · Balance 0 F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3: These shares vested on February 15, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis.
F2: These shares were acquired in connection with the company's separation from Varian Medical Systems, Inc. and were inadvertently omitted from column 5 in the Form 4 dated February 17, 2017
F3: These shares vested on February 15, 2018.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VARIAN MEDICAL SYSTEMS INC
Report date November 05, 2020 · Filed April 16, 2021
Section 16 reporting ended · disclosed 2021-04-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,864 |
Reported balance
After 2020-11-05 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2020-11-05 · Gift · Disposed 46,700 · Balance 35,864 |
| Common StockSEC Table I · non-derivative | Direct | 42,485 |
Reported balance
After 2021-02-08 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2021-02-08 · Gift · Disposed 15,460 · Balance 42,485 |
| Common StockSEC Table I · non-derivative | Direct | 39,087 |
Reported balance
After 2021-02-22 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2021-02-22 · Gift · Disposed 3,398 · Balance 39,087 |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 4
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 4 · 2021-04-15 · Disposition to issuer · Disposed 39,231 · Balance 0 F1: Amount of securities beneficially owned at end of reporting period reflect 144 shares purchased on April 8, 2021 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan. F2: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-04-15 · Disposition to issuer · Disposed 23,577 · Balance 0 F3: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F4: Pursuant to the Merger Agreement, these performance stock units, which were granted November 16, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-04-15 · Disposition to issuer · Disposed 20,763 · Balance 0 F3: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F5: Pursuant to the Merger Agreement, performance stock units, which were granted November 22, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. |
| Performance Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $58.74 | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-04-15 · Disposition to issuer · Disposed 163,361 · Balance 0 F6: Each performance stock option represents a contingent right to purchase one share of VAR common stock at the derivative security price. F7: Pursuant to the Merger Agreement, these performance stock options, which were granted November 16, 2018, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. |
| Performance Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $45.92 | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-04-15 · Disposition to issuer · Disposed 130,095 · Balance 0 F6: Each performance stock option represents a contingent right to purchase one share of VAR common stock at the derivative security price. F8: Pursuant to the Merger Agreement, these performance stock options, which were granted November 22, 2019, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-04-15 · Disposition to issuer · Disposed 21,613 · Balance 0 F9: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F10: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule. |
Filing footnotes · ownership attribution and instrument terms
F1: Amount of securities beneficially owned at end of reporting period reflect 144 shares purchased on April 8, 2021 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan.
F2: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
F3: Each performance stock unit represents a contingent right to receive one share of VAR common stock.
F4: Pursuant to the Merger Agreement, these performance stock units, which were granted November 16, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
F5: Pursuant to the Merger Agreement, performance stock units, which were granted November 22, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
F6: Each performance stock option represents a contingent right to purchase one share of VAR common stock at the derivative security price.
F7: Pursuant to the Merger Agreement, these performance stock options, which were granted November 16, 2018, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
F8: Pursuant to the Merger Agreement, these performance stock options, which were granted November 22, 2019, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
F9: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F10: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 19, 2026 Filed Mar 23, 2026 20:26 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 2,158 | $111.75 | $241,156.50 |
DisclosureSEC source: 0001090872-26-000033 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,368.606 F1 · price: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. F2 · balance_after: 144.124 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 14:06 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 1,819 | $121.18 | $220,426.42 |
DisclosureSEC source: 0001127602-25-009726 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,066.482 F1 · shares: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of these shares of common stock. F2 · balance_after: 111.123 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:28 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 1,678 | $147.48 | $247,471.44 |
DisclosureSEC source: 0001127602-24-010688 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,136.359 F1 · shares: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer these shares of common stock. F2 · balance_after: 108.373 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock. Read SEC document |
| March 16, 2023 Filed Mar 21, 2023 01:41 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 1,658 | $136.82 | $226,847.56 |
DisclosureSEC source: 0000899243-23-009226 · doc4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,349.986 F1 · shares: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of these shares of common stock. F2 · balance_after: 81.157 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock. Read SEC document |
| March 17, 2022 Filed Mar 21, 2022 21:13 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 1,785 | $136.82 | $244,223.70 |
DisclosureSEC source: 0001127602-22-010057 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,610.829 F1 · shares: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of these shares of common stock. F2 · balance_after: 59.3210 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerRestricted Stock Units · Derivative | 21,613 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-013922 · form4.xml · derivative · entry 9 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,613 shares Expires not disclosed F9 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F10 · price: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule. F10 · derivative.exercise_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule. F10 · derivative.expiration_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerPerformance Stock Option · Derivative | 130,095 | $131.58 Strike: $45.92 | $17,117,900.10 |
DisclosureSEC source: 0001127602-21-013922 · form4.xml · derivative · entry 8 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 130,095 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock option represents a contingent right to purchase one share of VAR common stock at the derivative security price. F8 · price: Pursuant to the Merger Agreement, these performance stock options, which were granted November 22, 2019, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. F8 · derivative.exercise_date: Pursuant to the Merger Agreement, these performance stock options, which were granted November 22, 2019, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. F8 · derivative.expiration_date: Pursuant to the Merger Agreement, these performance stock options, which were granted November 22, 2019, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerPerformance Stock Option · Derivative | 163,361 | $118.76 Strike: $58.74 | $19,400,752.36 |
DisclosureSEC source: 0001127602-21-013922 · form4.xml · derivative · entry 7 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 163,361 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock option represents a contingent right to purchase one share of VAR common stock at the derivative security price. F7 · price: Pursuant to the Merger Agreement, these performance stock options, which were granted November 16, 2018, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. F7 · derivative.exercise_date: Pursuant to the Merger Agreement, these performance stock options, which were granted November 16, 2018, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. F7 · derivative.expiration_date: Pursuant to the Merger Agreement, these performance stock options, which were granted November 16, 2018, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerPerformance Shares · Derivative | 20,763 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-013922 · form4.xml · derivative · entry 6 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,763 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F5 · price: Pursuant to the Merger Agreement, performance stock units, which were granted November 22, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, performance stock units, which were granted November 22, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. F5 · derivative.expiration_date: Pursuant to the Merger Agreement, performance stock units, which were granted November 22, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerPerformance Shares · Derivative | 23,577 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-013922 · form4.xml · derivative · entry 5 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,577 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F4 · price: Pursuant to the Merger Agreement, these performance stock units, which were granted November 16, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. F4 · derivative.exercise_date: Pursuant to the Merger Agreement, these performance stock units, which were granted November 16, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. F4 · derivative.expiration_date: Pursuant to the Merger Agreement, these performance stock units, which were granted November 16, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerCommon Stock | 39,231 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-013922 · form4.xml · nonDerivative · entry 4 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Amount of securities beneficially owned at end of reporting period reflect 144 shares purchased on April 8, 2021 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan. F2 · price: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 19:27 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 1,850 | $121.59 | $224,947.05 |
DisclosureSEC source: 0001127602-21-011660 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,766.508 F1 · shares: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of these shares of common stock. F2 · balance_after: 60.162 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. Read SEC document |
| February 22, 2021 Filed Apr 16, 2021 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 3,398 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-013922 · form4.xml · nonDerivative · entry 3 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,087 Read SEC document |
| February 08, 2021 Filed Apr 16, 2021 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 15,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-013922 · form4.xml · nonDerivative · entry 2 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,485 Read SEC document |
| December 10, 2020 Filed Dec 10, 2020 20:24 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 16,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031131 · form4.xml · nonDerivative · entry 3 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,645 Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 20:24 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 159,198 | $0.00 Strike: $109.03 | $0.00 |
DisclosureSEC source: 0001127602-20-031131 · form4.xml · derivative · entry 5 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 159,198 shares Expires 2024-11-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule 10b5-1 trading plan F3 · derivative.exercise_date: Represents performance-based stock option award granted on November 17, 2017 which vested on November 21, 2020, the date the Compensation Committee of the Board of Directors determined that the performance criteria were satisfied. F3 · derivative.expiration_date: Represents performance-based stock option award granted on November 17, 2017 which vested on November 21, 2020, the date the Compensation Committee of the Board of Directors determined that the performance criteria were satisfied. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 20:24 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 159,198 | $174.40 | $27,764,720.23 |
DisclosureSEC source: 0001127602-20-031131 · form4.xml · nonDerivative · entry 2 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,445 F1 · kind: This transaction is pursuant to the filer's SEC Rule 10b5-1 trading plan F2 · price: The 159,198 shares were sold in multiple transactions executed on the same day at prices ranging from $174.365 to $174.49. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 20:24 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 159,198 | $109.03 | $17,357,357.94 |
DisclosureSEC source: 0001127602-20-031131 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule 10b5-1 trading plan Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 20:53 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 75,015 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-20-031043 · form4.xml · derivative · entry 6 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,015 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F5 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 20:53 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 111,830 | $0.00 Strike: $81.97 | $0.00 |
DisclosureSEC source: 0001127602-20-031043 · form4.xml · derivative · entry 5 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 111,830 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 2/13/2016, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 20:53 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 75,015 | $174.35 | $13,079,120.30 |
DisclosureSEC source: 0001127602-20-031043 · form4.xml · nonDerivative · entry 4 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,445 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 75,015 shares were sold in multiple transactions executed on the same day at prices ranging from $174.31 to $174.44. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 20:53 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 75,015 | $80.40 | $6,031,206.00 |
DisclosureSEC source: 0001127602-20-031043 · form4.xml · nonDerivative · entry 3 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 20:53 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 82,500 | $174.35 | $14,383,974.00 |
DisclosureSEC source: 0001127602-20-031043 · form4.xml · nonDerivative · entry 2 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,445 F2 · price: The 82,500 shares were sold in multiple transactions executed on the same day at prices ranging from $174.31 to $174.41. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 20:53 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 111,830 | $81.97 | $9,166,705.10 |
DisclosureSEC source: 0001127602-20-031043 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 19:05 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 9,401 | $173.50 | $1,631,073.50 |
DisclosureSEC source: 0001127602-20-030037 · form4.xml · nonDerivative · entry 2 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,115 F2 · shares: Represents shares withheld from vested PSUs for the payment of federal, state and payroll taxes due on settlement. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 19:05 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantCommon Stock | 18,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030037 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,516 F1 · shares: Represents shares issued upon settlement of performance-based unit award (PSUs) granted on November 16, 2017. Read SEC document |
| November 21, 2020 Filed Dec 10, 2020 20:24 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 159,198 | $109.03 Strike: $109.03 | $17,357,357.94 |
DisclosureSEC source: 0001127602-20-031131 · form4.xml · derivative · entry 4 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,198 Underlying: Common Stock · 159,198 shares Expires 2024-11-17 F3 · derivative.exercise_date: Represents performance-based stock option award granted on November 17, 2017 which vested on November 21, 2020, the date the Compensation Committee of the Board of Directors determined that the performance criteria were satisfied. F3 · derivative.expiration_date: Represents performance-based stock option award granted on November 17, 2017 which vested on November 21, 2020, the date the Compensation Committee of the Board of Directors determined that the performance criteria were satisfied. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 19:01 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 21,613 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-029967 · form4.xml · derivative · entry 1 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,613 Underlying: Common Stock · 21,613 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on November 21, 2021, November 21, 2022 and November 21, 2023. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on November 21, 2021, November 21, 2022 and November 21, 2023. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| November 05, 2020 Filed Apr 16, 2021 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 46,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-013922 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,864 Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 13:15 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 38,907 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-20-025624 · form4.xml · derivative · entry 3 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 38,907 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan. F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 11/09/2013, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 13:15 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 38,907 | $172.43 | $6,708,730.12 |
DisclosureSEC source: 0001127602-20-025624 · form4.xml · nonDerivative · entry 2 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,564 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan. F2 · price: The 38,907 shares were sold in multiple transactions executed on the same day at prices ranging from $172.03 to $172.72. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 13:15 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 38,907 | $67.12 | $2,611,437.84 |
DisclosureSEC source: 0001127602-20-025624 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan. Read SEC document |
| August 21, 2020 Filed Aug 24, 2020 11:52 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 38,907 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-20-024094 · form4.xml · derivative · entry 3 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,907 Underlying: Common Stock · 38,907 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 11/09/2013, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| August 21, 2020 Filed Aug 24, 2020 11:52 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 38,907 | $172.63 | $6,716,332.55 |
DisclosureSEC source: 0001127602-20-024094 · form4.xml · nonDerivative · entry 2 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,564 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 38,907 shares were sold in multiple transactions executed on the same day at prices ranging from $172.45 to $172.99. The detailed breakdown of executed sales will be furnished upon request. F3 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 206 shares purchased on May 1, 2020 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan. Read SEC document |
| August 21, 2020 Filed Aug 24, 2020 11:52 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 38,907 | $67.12 | $2,611,437.84 |
DisclosureSEC source: 0001127602-20-024094 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| April 17, 2020 Filed Apr 21, 2020 23:48 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 3,081 | $73.01 | $224,940.73 |
DisclosureSEC source: 0001127602-20-014251 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,856.346 F1 · shares: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of these shares of common stock. F2 · balance_after: 49.875 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 15:39 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 38,909 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-20-011238 · form4.xml · derivative · entry 3 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,814 Underlying: Common Stock · 38,909 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 11/09/2013, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 15:39 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 38,909 | $110.00 | $4,279,990.00 |
DisclosureSEC source: 0001127602-20-011238 · form4.xml · nonDerivative · entry 2 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,358 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 15:39 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 38,909 | $67.12 | $2,611,572.08 |
DisclosureSEC source: 0001127602-20-011238 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:47 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 5,017 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006778 · form4.xml · derivative · entry 4 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,017 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on November 21, 2013, November 21, 2014, and November 21, 2015. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on November 21, 2013, November 21, 2014, and November 21, 2015. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:47 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 1,619 | $145.90 | $236,212.10 |
DisclosureSEC source: 0001127602-20-006778 · form4.xml · nonDerivative · entry 3 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,358 Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:47 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 5,017 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006778 · form4.xml · nonDerivative · entry 2 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| January 10, 2020 Filed Jan 13, 2020 18:24 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 2,955 | $146.62 | $433,262.10 |
DisclosureSEC source: 0001127602-20-001480 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,250 F1 · shares: Represents shares withheld from vested restricted stock for the payment of federal, state and payroll taxes due on vesting. Read SEC document |
| December 11, 2019 Filed Feb 20, 2020 19:47 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GiftCommon Stock | 245 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006778 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,960 Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 17:05 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 14,251 | $129.97 | $1,852,202.47 |
DisclosureSEC source: 0001127602-19-033692 · form4.xml · nonDerivative · entry 2 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,205 F2 · shares: Represents shares withheld from vested PSUs for the payment of federal, state and payroll taxes due on settlement. F3 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 226 shares purchased on April 26, 2019 and 2 shares purchased on October 25, 2019 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 17:05 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantCommon Stock | 28,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-033692 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,456 F1 · shares: Represent shares issued upon settlement of performance-based unit award (PSUs) granted December 8, 2016. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 19:30 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 45,050 | $0.00 Strike: $74.06 | $0.00 |
DisclosureSEC source: 0001127602-19-014338 · form4.xml · derivative · entry 4 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,050 shares Expires 2021-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 02/21/2015, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 19:30 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 33,051 | $141.73 | $4,684,255.43 |
DisclosureSEC source: 0001127602-19-014338 · form4.xml · nonDerivative · entry 3 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,483 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 33,051 shares were sold in multiple transactions executed on the same day at prices ranging from $141.55 to $142.06. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 19:30 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 11,999 | $141.18 | $1,693,963.62 |
DisclosureSEC source: 0001127602-19-014338 · form4.xml · nonDerivative · entry 2 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,534 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 11,999 shares were sold in multiple transactions executed on the same day at prices ranging from $140.55 to $141.54. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 19:30 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 45,050 | $74.06 | $3,336,403.00 |
DisclosureSEC source: 0001127602-19-014338 · form4.xml · nonDerivative · entry 1 WILSON DOW R · CIK 0001313996 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.